Discovery Labs (DSCO +9.4%) shoots up on chatter that the firm may be in line to land FDA...

|By:, SA News Editor

Discovery Labs (DSCO +9.4%) shoots up on chatter that the firm may be in line to land FDA approval on Surfaxin for the treatment of respiratory illness in infants.